Christopher M. Hoffmann
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in ⓘ
- Oncology 12
- Lung Cancer Research Studies 6
- Cancer Cells and Metastasis 5
- Pancreatic and Hepatic Oncology Research 2
- HER2/EGFR in Cancer Research 2
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Hanno Glimm (7 shared papers)Claudia R. Ball (7 shared papers)Sebastian M. Dieter (5 shared papers)Friederike Herbst (3 shared papers)Wilko Weichert (3 shared papers)Manfred Schmidt (4 shared papers)Jürgen Weitz (3 shared papers)Ulrich Abel (2 shared papers)
In The Last Decade
Christopher M. Hoffmann
12 papers receiving 450 citations
Peers
Comparison fields: 5 of 55
- Oncology 313
- Cancer Research 129
- Biotechnology 45
- Molecular Biology 228
- Genetics 86
Countries citing papers authored by Christopher M. Hoffmann
This map shows the geographic impact of Christopher M. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Hoffmann more than expected).
Fields of papers citing papers by Christopher M. Hoffmann
This network shows the impact of papers produced by Christopher M. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Hoffmann. The network helps show where Christopher M. Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher M. Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 225 | |
| 2 | 2013 | 100 | |
| 3 | 2012 | 53 | |
| 4 | 2017 | 27 | |
| 5 | 2019 | 20 | |
| 6 | 2021 | 10 | |
| 7 | 2015 | 8 | |
| 8 | 2021 | 7 | |
| 9 | 2019 | 2 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 1 | |
| 12 | 2010 | 1 | |
| 13 | 2021 | 0 | |
| 14 | 2008 | 0 | |
| 15 | 2019 | 0 |
About Christopher M. Hoffmann
Christopher M. Hoffmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Biotechnology and Cancer Research, having authored 15 papers that have together received 456 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (6 papers), Cancer Cells and Metastasis (5 papers), Cancer Research and Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (313 citations), Cancer Research (129 citations), Biotechnology (45 citations), Molecular Biology (228 citations) and Genetics (86 citations). Christopher M. Hoffmann has collaborated with scholars based in Germany, Spain and China. Frequent co-authors include Hanno Glimm, Claudia R. Ball, Sebastian M. Dieter, Friederike Herbst, Wilko Weichert, Manfred Schmidt, Jürgen Weitz, Ulrich Abel, Christof von Kalle and Moritz Koch. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Radiotherapy and Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.